Multiple myeloma and hypercoagulability leading to internal jugular vein thrombosis in a dialysis patient

Hemodialysis International

Volumn 11, Issue 1, 2007, Pages 35-37

  Pratap, Balaji ^a   Gupta, Punit ^a   Kumar, Praveen ^a   Abraham, Georgi ^a   Santhanam, Ramalakshmi ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Antithrombin III; Hemodialysis; Multiple myeloma; Thrombus

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; BENCE JONES PROTEIN; CALCIUM; CEFPIROME; CREATININE; GLOBULIN; HEMOGLOBIN; HOMOCYSTEINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPROTEIN A; LOW MOLECULAR WEIGHT HEPARIN; NITROGEN; OFLOXACIN; PARATHYROID HORMONE; PHOSPHORUS; PROTEIN C; PROTEIN S; UREA; URIC ACID; WARFARIN;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACKACHE; BONE BIOPSY; BRONCHOPNEUMONIA; CALCIUM BLOOD LEVEL; CASE REPORT; CATHETER REMOVAL; CATHETER THROMBOSIS; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE BLOOD LEVEL; CYTOPLASM; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; ESCHERICHIA COLI; FEVER; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; HYPERCOAGULABILITY; INTERNAL JUGULAR VEIN; KLEBSIELLA; LEUKOCYTE COUNT; LUNG LAVAGE; MALE; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CELL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; SUBCLAVIAN VEIN; SUPERIOR CAVA VEIN; SWELLING; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL; VEIN THROMBOSIS;

AGED; ANTICOAGULANTS; CATHETERIZATION; DIALYSIS; HUMANS; JUGULAR VEINS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE MYELOMA; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 33846401806     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2007.00150.x     Document Type: Article

References (11)

1. Paoletti F, Ripani U, Antonelli M, Nicoletta G. Observations of the implantation technique and its complications. Minerva Anestesiol. 2005; 71: 555-560.
2. Greenlee RT, Murray T, Bolden S, et al. Cancer stats. CA Cancer J Clin. 2000; 50: 7.
3. Assouad M, Eknoyan G. Does the choice of renal replacement therapy adversely affect the hypercoagulability associated with renal disease? Am J Nephrol. 1998; 18: 175-178.
4. Tallman MS, Kwaan HC. Intravascular clotting activation and bleeding in patients with hematologic malignancies. Rev Clin Exp Hematol. 2004; 8: E1.
5. Perkins H, MacKenzie M, Fudenberg H. Hemostatic defects in dysproteinemias. Blood. 1970; 35: 695.
6. Robert F, Mignucci M, McCurdy SA, et al. Hemostatic abnormalities associated with monoclonal gammopathies. Am J Med Sci. 1993; 306: 359.
7. Siami GA, Siami FS. Plasmapheresis and paraproteinemia: Cryo-protein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma. Ther Apher. 1999; 3: 8.
8. Caruana RJ, Raja RM, Zeit RM, et al. Thrombotic complications of indwelling central catheters used for chronic hemodialysis. Am J Kidney Dis. 1987; 9: 497-501.
9. Van Marion AM, Auwerda JJ, Minnema MC, et al. Hypofibrinolysis during induction treatment of multiple myeloma may increase the risk of venous thrombosis. Thromb Haemost. 2005; 94: 1341-1343.
10. Spicka I, Cieslar P, et al. Disorders of anticoagulation and fibrinolysis in monoclonal gammopathies-another mechanism of paraprotein interference with hemostasis. Sb Lek. 1996; 97: 369-375.
11. Iggo N, Palmer AB, Severn A, Chronic dialysis in patients with multiple myeloma and renal failure: A worthwhile treatment. Q J Med. 1989; 73: 903-910.